Anorexia in cancer: role of feeding-regulatory peptides
- 15 June 2006
- journal article
- review article
- Published by The Royal Society in Philosophical Transactions B
- Vol. 361 (1471), 1281-1289
- https://doi.org/10.1098/rstb.2006.1863
Abstract
Anorexia is one of the most common symptoms in advanced cancer and is a frequent cause of discomfort for cancer patients and their families. The pathogenesis of cancer anorexia is multi-factorial and involves most of the hypothalamic neuronal signalling pathways modulating energy homeostasis. It is considered to be the result of a failure of usual appetite and satiety signals. Loss of appetite can arise from decreased taste and smell of food, as well as from dysfunctional hypothalamic signalling pathways and cytokine production. Cytokines in particular, appear to play a key role in energy balance through persistent activation of the melanocortin system and inhibition of the neuropeptide Y pathway. The imbalance between anorexigenic and orexigenic peptides leads to suppression of appetite, and increased satiety and satiation associated with marked weight loss and decline in physical performance. High levels of serotonin also appear to contribute to these effects and recent findings implicate corticotropin-releasing factor in the pathogenesis of cancer anorexia as well. Despite significant advances in our understanding of the regulation of food intake and energy expenditure, few effective therapies are available. A better appreciation of the molecular and neuronal mechanisms that control body weight homeostasis may lead to the development of new therapies for improving the survival and quality of life of these patients.Keywords
This publication has 98 references indexed in Scilit:
- Prevention of Cancer Cachexia by a Novel Nuclear Factor κB Inhibitor in Prostate CancerClinical Cancer Research, 2005
- Hypothalamic 5-HT1B-receptor changes in anorectic tumor bearing ratsNeuroscience Letters, 2005
- Therapy Insight: cancer anorexia–cachexia syndrome—when all you can eat is yourselfNature Clinical Practice Oncology, 2005
- Adipose tissue in Walker 256 tumour-induced cachexia: possible association between decreased leptin concentration and mononuclear cell infiltrationCell and tissue research, 2004
- Body Weight Regulation by Selective MC4 Receptor Agonists and AntagonistsAnnals of the New York Academy of Sciences, 2003
- Managing Cancer-Related Anorexia/CachexiaDrugs, 2001
- Cancer cachexiaSurgical Oncology, 1999
- Low-Dose Oral Use of Human Interferon-alpha in Cancer PatientsJournal of Interferon & Cytokine Research, 1999
- Serum levels of tumour necrosis factor alpha and other cytokines do not correlate with weight loss and anorexia in cancer patientsSupportive Care in Cancer, 1997
- Anti-interferon-γ antibody treatment, growth of Lewis lung tumours in mice and tumour-associated cachexiaEuropean Journal of Cancer and Clinical Oncology, 1991